Benjamin Edwards Inc. Boosts Holdings in The Clorox Company (NYSE:CLX)

by · The Cerbat Gem

Benjamin Edwards Inc. lifted its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 0.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,894 shares of the company’s stock after buying an additional 526 shares during the quarter. Benjamin Edwards Inc.’s holdings in Clorox were worth $10,381,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Brooklyn Investment Group grew its holdings in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Redwood Park Advisors LLC bought a new stake in shares of Clorox during the fourth quarter valued at approximately $26,000. Millstone Evans Group LLC purchased a new stake in Clorox in the fourth quarter worth $31,000. Asset Planning Inc bought a new position in Clorox in the fourth quarter worth $32,000. Finally, GKV Capital Management Co. Inc. purchased a new position in Clorox during the fourth quarter valued at $32,000. 78.53% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI raised their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays dropped their price target on Clorox from $139.00 to $134.00 and set an “underweight” rating on the stock in a research report on Friday, April 11th. DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Finally, Citigroup dropped their target price on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Clorox presently has an average rating of “Hold” and an average price target of $153.83.

Get Our Latest Research Report on CLX

Clorox Trading Up 0.2 %

Shares of NYSE:CLX opened at $138.88 on Monday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock’s fifty day moving average price is $144.14 and its 200-day moving average price is $154.85. The company has a market cap of $17.11 billion, a P/E ratio of 37.95, a PEG ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the company posted $2.16 EPS. Sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.51%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).